Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etavopivat food effect study in healthy volunteers
NCT06433661Phase 1Completed
- Sponsor
- Novo Nordisk
- Start
- May 2024
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of etavopivat (2 arms), sponsored by Novo Nordisk. Primary endpoints: Area Under the Plasma Concentration-Time Curve from 0 Hours to Infinity and Maximum Observed Plasma Concentration. Started May 2024; status: completed.
02
Drugs
etavopivat
Beyond the preview
Go deeper on NCT06433661.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06433661.